STING/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease

Li Gao,Junsheng Zhang,Tingting Yang,Ling Jiang,Xueqi Liu,Sheng Wang,Xian Wang,Yuebo Huang,Huaying Wang,Mengya Zhang,Tingting Gong,Lijuan Ma,Chao Li,Chaoyong He,Xiao-ming Meng,Yonggui Wu

DOI: https://doi.org/10.1016/j.ymthe.2023.07.026

IF: 12.91

2023-01-01

Molecular Therapy

Abstract:Hypertension is a primary modifiable risk factor for cardiovas-cular diseases, which often induces renal end-organ damage and complicates chronic kidney disease (CKD). In the present study, histological analysis of human kidney samples revealed that hypertension induced mtDNA leakage and promoted the expression of stimulator of interferon genes (STING) in renal epithelial cells. We used angiotensin II (AngII)-and 2K1C-treated mouse kidneys to elucidate the underlying mechanisms. Abnormal renal mtDNA packing caused by AngII promoted STING-dependent production of inflammatory cytokines, macrophage infiltration, and a fibrogenic response. STING knockout significantly decreased nuclear factor -KB activation and immune cell infiltration, attenuating tubule atrophy and extracellular matrix accumulation in vivo and in vitro. These effects delayed CKD progression. Immunoprecipita-tion assays and liquid chromatography-tandem mass spec-trometry showed that STING and ACSL4 were directly combined at the D53 and K412 amino acids of ACSL4. Furthermore, STING induced renal inflammatory response and fibrosis through ACSL4-dependent ferroptosis. Last, inhi-bition of ACSL4 using small interfering RNA, rosiglitazone, or Fer-1 downregulated AngII-induced mtDNA-STING-depen-dent renal inflammation. These results suggest that targeting the STING/ACSL4 axis might represent a potential strategy for treating hypertension-associated CKD.